Intellipharmaceutics International Analysis
| IPCIFDelisted Stock | USD 0.05 0.00 0.00% |
Intellipharmaceutics International is overvalued with Real Value of 0.0468 and Hype Value of 0.05. The main objective of Intellipharmaceutics otc analysis is to determine its intrinsic value, which is an estimate of what Intellipharmaceutics International is worth, separate from its market price. There are two main types of Intellipharmaceutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Intellipharmaceutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Intellipharmaceutics' stock to identify patterns and trends that may indicate its future price movements.
The Intellipharmaceutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Intellipharmaceutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Intellipharmaceutics OTC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Intellipharmaceutics' ongoing operational relationships across important fundamental and technical indicators.
Intellipharmaceutics |
Intellipharmaceutics OTC Stock Analysis Notes
The company recorded a loss per share of 0.16. Intellipharmaceutics last dividend was issued on the 14th of September 2018. The entity had 1:10 split on the 14th of September 2018. Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.The quote for Intellipharmaceutics International is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Intellipharmaceutics International call the company at 416 798 3001 or check out https://www.intellipharmaceutics.com.Intellipharmaceutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Intellipharmaceutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Intellipharmaceutics International or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Intellipharmaceutics is not yet fully synchronised with the market data | |
| Intellipharmaceutics has some characteristics of a very speculative penny stock | |
| Intellipharmaceutics has a very high chance of going through financial distress in the upcoming years | |
| Intellipharmaceutics has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company has accumulated 2.01 M in total debt with debt to equity ratio (D/E) of 165.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intellipharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intellipharmaceutics until it has trouble settling it off, either with new capital or with free cash flow. So, Intellipharmaceutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intellipharmaceutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intellipharmaceutics to invest in growth at high rates of return. When we think about Intellipharmaceutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (5.15 M) with profit before overhead, payroll, taxes, and interest of 1.4 M. | |
| Intellipharmaceutics International has accumulated about 79.65 K in cash with (2.46 M) of positive cash flow from operations. |
Intellipharmaceutics Upcoming and Recent Events
Earnings reports are used by Intellipharmaceutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Intellipharmaceutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of June 2024 Upcoming Quarterly Report | View | |
| 30th of November 2023 Next Fiscal Quarter End | View |
Intellipharmaceutics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intellipharmaceutics's market, we take the total number of its shares issued and multiply it by Intellipharmaceutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Intellipharmaceutics Predictive Daily Indicators
Intellipharmaceutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Intellipharmaceutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Intellipharmaceutics OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Intellipharmaceutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intellipharmaceutics shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Intellipharmaceutics. By using and applying Intellipharmaceutics OTC Stock analysis, traders can create a robust methodology for identifying Intellipharmaceutics entry and exit points for their positions.
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Intellipharmaceutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |